New Jersey Assembly Bill 2830 (Prior Session Legislation)

---

Spectrum: Partisan Bill (Democrat 3-0)
Status: Introduced on February 20 2020 - 25% progression, died in committee
Action: 2020-02-20 - Introduced, Referred to Assembly Financial Institutions and Insurance Committee
Pending: Assembly Financial Institutions and Insurance Committee
Text: Latest bill text (Introduced) [HTML]

Requires health benefits coverage for buprenorphine and buprenorphine/naloxone for pain treatment without step therapy or fail-first protocols.

Requires health benefits coverage for buprenorphine and buprenorphine/naloxone for pain treatment without step therapy or fail-first protocols.

Rep. Carol Murphy [D]

Rep. Valerie Huttle [D]

Rep. Annette Chaparro [D]

Date	Chamber	Action
2020-02-20	Assembly	Introduced, Referred to Assembly Financial Institutions and Insurance Committee

A2830 (Carry Over) 2020-02-20 - Introduced, Referred to Assembly Financial Institutions and Insurance Committee
A2830 (Carry Over) 2020-02-20 - Introduced, Referred to Assembly Financial Institutions and Insurance Committee
S1650 (Same As) 2020-02-13 - Introduced in the Senate, Referred to Senate Commerce Committee
S4051 (Carry Over) 2019-08-23 - Introduced in the Senate, Referred to Senate Commerce Committee
A5719 (Carry Over) 2019-08-23 - Introduced, Referred to Assembly Financial Institutions and Insurance Committee

Type	Source
Summary	https://www.njleg.state.nj.us/bill-search/2020/A2830
Text	https://pub.njleg.gov/Bills/2020/A3000/2830_I1.HTM